PATENT CLAIM ANALYSIS

Application Number: 15741881
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "190100"]

Abstract:
Disclosed are immunogenic proteins from  Pseudomonas aeruginosa  as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with  Pseudomonas aeruginosa  using the proteins, nucleic acids, vectors or transformed cells.

Claim (Index 4):
The polypeptide according to  claim 1 , wherein the sequence identity with the amino acid sequence of b) is at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, and at least 99%.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.56667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16099254', '14638956', '14387514', '15542580', '14078367']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7569596020300786
- 35 USC 102 Novelty (BERT): 0.5179874573026994
- Combined Prediction Score: 0.7330623875573408
- Mean Citation Score: 284.531622
- Max Citation Score: 291.72742
- Similarity Product: 186.081269548459

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test